Mary Beth Seaman

Mary Beth Seaman serves as the Director of Quality Risk Management at Galapagos since May 2025, following a tenure as Associate Director of Quality and Risk at Adaptimmune from November 2017 to May 2025, where responsibilities included regulatory inspection preparations and management of Quality Risk Programs. Prior experience at GSK spanned from 1991 to July 2017, including roles such as Product Quality Leader, GMP Compliance Manager, and Senior Quality Assurance Investigator, focusing on quality risk management, GMP compliance, and training. Mary Beth Seaman holds a Master of Science and a Bachelor of Science in Chemistry from Saint Joseph's University.